Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-08

Clinical Trial Update: Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing fixed versus weight-based enoxaparin dosing in thoracic surgery patients has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: University of Utah | Conditions: Venous Thromboembolism, Deep Venous Thrombosis | Phase 2 | Status: COMPLETED | Results posted: 2020-07-08